Chang, Shuaibin
Varadarajan, Divya
Yang, Jiarui
Chen, Ichun Anderson
Kura, Sreekanth
Magnain, Caroline
Augustinack, Jean C.
Fischl, Bruce
Greve, Douglas N.
Boas, David A.
Wang, Hui
Funding for this research was provided by:
National Institutes of Health (U01MH117023)
National Institute for Biomedical Imaging and Bioengineering (P41EB015896, 1R01EB02328, 1R01EB006758, R21EB018907, R01EB019956, P41EB030006)
National Institute on Aging (1R56AG064027, 1R01AG064027, 5R01AG008122, R01AG016495)
National Institute of Mental Health (R01 MH123195, R01 MH121885)
National Institute for Neurological Disorders and Stroke (R01NS0525851, R21NS072652, R01NS070963, R01NS083534, 5U01NS086625, 5U24NS10059103, R01NS105820)
NIH Blueprint for Neuroscience Research (5U01-MH093765)
Chan Zuckerberg Initiative (2019-189101)
Article History
Received: 1 September 2021
Accepted: 3 December 2021
First Online: 10 January 2022
Competing interests
: Bruce Fischl has a financial interest in CorticoMetrics, a company whose medical pursuits focus on brain imaging and measurement technologies. BF's interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.